Cho K J, Andrews J C, Williams D M, Doenz F, Guy G E
Department of Radiology, University of Michigan Medical Center, Ann Arbor 48109-0030.
Radiology. 1989 Dec;173(3):783-91. doi: 10.1148/radiology.173.3.2813787.
Hepatic arterial infusion chemotherapy increases the hepatic concentration of chemotherapeutic agents without increasing systemic toxicity. Both percutaneous (most commonly left transbrachial) and surgical approaches are currently used for infusion catheter placement. Surgical catheter and pump placement has proved to be a reliable means of delivering drugs to the liver and has been commonly used for hepatic arterial chemotherapy for metastatic colorectal carcinoma. Meticulous angiographic evaluation of the hepatic vascular anatomy, its variations, and hemodynamics is necessary for correct catheter placement to achieve total liver perfusion without significant extrahepatic perfusion. Satisfactory hepatic perfusion should be documented before drug infusion. Hepatic arterial radionuclide flow imaging with technetium-99m-labeled macroaggregated serum albumin remains the most reliable means of assessing hepatic perfusion following catheter placement. Transcatheter techniques have been used to facilitate catheter placement, to prevent gastrointestinal drug toxicity, and to correct unsatisfactory perfusion following surgical catheter placement.
肝动脉灌注化疗可提高化疗药物在肝脏中的浓度,而不增加全身毒性。目前经皮(最常见的是经左肱动脉)和手术途径均用于放置灌注导管。手术放置导管和泵已被证明是将药物输送到肝脏的可靠方法,并且已普遍用于转移性结直肠癌的肝动脉化疗。为了正确放置导管以实现全肝灌注而无明显肝外灌注,需要对肝血管解剖结构、其变异情况和血流动力学进行细致的血管造影评估。在药物输注前应记录满意的肝灌注情况。使用99m锝标记的大颗粒聚合血清白蛋白进行肝动脉放射性核素血流成像是评估导管放置后肝灌注的最可靠方法。经导管技术已被用于促进导管放置、预防胃肠道药物毒性以及纠正手术放置导管后不满意的灌注情况。